Korea Biopharma Shares Rally...Algonomics Soars 300% on Debut[K bio Pulse]
[Seungkwon kim, Edaily reporter] Stocks in South Korea’s pharmaceuticals, biotech and healthcare sector rallied on Dec.
18 led by names tied to new drug development regenerative medicine and bio-manufacturing (ODM/OEM) each backed by distinct growth narratives.
Algonomics, OrganoidScience and T&R Biofab were among the notable gainers.
뉴스픽의 주요 문장 추출 기술을 사용하여 “이데일리” 기사 내용을 3줄로 요약한 결과입니다. 일부 누락된 내용이 있어 전반적인 이해를 위해서는 본문 전체 읽기를 권장합니다.
